About Invokana® »

Invokana® (canagliflozin) is a drug prescribed to treat Type 2 diabetes. It belongs to a new class of drugs referred to as “Sodium Glucose co-transporter 2 (SGLT2) inhibitors.” Approved for sale by the FDA in 2013, Invokana® was the first of this new class to be sold in the United States. Invokana® and its related drugs, Invokamet and Invokamet XR are manufactured and sold by Johnson & Johnson and its subsidiary Janssen Pharmaceuticals. Other SGLT2 inhibitors - Farxiga and Xigduo XR (Astra Zeneca) and Jardiance and Glyxambi (Boehringer Ingelheim & Eli Lilly) – were subsequently approved for sale in the U.S. Each of these drugs comes in two forms: one as the sole drug and the other as a combination drug that includes the branded drug.

Invokana Amputations

Invokana® Injury Risks »

In 2017 the FDA issued a Drug Safety Communication confirming that patients taking Invokana®, Invokamet and Invokamet XR are at an increased risk of leg and foot amputations and that the manufacturers (Johnson & Johnson and its subsidiary Janssen Pharmaceuticals) must include a “Black Box Warning” on the drugs’ labeling.The Drug Safety Communication was issued after the FDA reviewed data from two different clinical trials – the CANVAS and CANVAS-R studies. These data demonstrated that diabetes patients treated with Invokana, Invokamet and Invokamet XR were twice as likely to require leg and foot amputations than those diabetes patients who were taking placebo (a non-drug). A number of case reports published in scientific literature followed by several adverse health reports to the FDA and an announcement by Health Canada point to a possible association between the use of SGLT2 inhibitors and an increased risk of Pancreatitis. Pancreatitis is a serious condition from which approximately one in every ten patients diagnosed will die. Also, on August 29, 2018 the FDA issued an urgent Safety Announcement to health care professionals and their patients. The Alert warned about the association between Invokana®/Invokamet®/Invokamet XR® (and other SGLT2 diabetes medications such as Jardiance®) and Fournier’s Gangrene, a life-threatening genital infection that can affect both men and women.

Case Evaluation

Case Evaluation »

We are currently accepting potential claims against the makers of Invokana® by users who have experienced serious adverse side effects including amputation of the legs, feet and/or toes, acute pancreatitis or Fournier’s Gangrene. If you or a loved one has been injured due to use of Invokana®, we would like to speak with you. Please call us toll-free at 1-888-276-3030 or send us your contact information and we will respond promptly.


Please fill in the form to request a FREE case evaluation from one of our attorneys if you or a loved one has suffered a Lower Limb Amputation, Fournier’s Gangrene (necrotizing fasciitis) or Pancreatitis while taking Invokana® or Invokamet® XR.

Have you or someone you know suffered a Lower Limb Amputation, Fournier’s Gangrene or Pancreatitis while taking Invokana® or Invokamet® XR? *
 All personal information will be kept private.

Reasons To Hire

  1. Our Mission is Excellence
  2. Thorough and diligent review and analysis of your case
  3. Proven Track Record
  4. Excellent Legal Representation
  5. Attention to Detail
  6. Dedication to our Craft
  7. Access to Leading Experts
  8. Updates on Litigation
  9. Concern for Your Well-being as well as Your Legal Rights
  10. No Fee Unless You Recover